论文部分内容阅读
目的:观察并探讨奥曲肽联合乌司他丁治疗急性胰腺炎的临床效果。方法:选择我院2011年2月至2013年12月70例急性胰腺炎患者作为探讨对象。随机将患者分为观察组(35例)和对照组(35例)。对照组给予奥曲肽进行治疗,观察组患者在此基础上加用乌司他丁。比较两组患者临床治疗效果。结果:观察组总有效率为91.4%,明显高于对照组(74.3%);且观察组患者血淀粉酶恢复正常时间、平均住院时间均优于对照组,两组差异具有统计学意义(P<0.05)。结论:奥曲肽联合乌司他丁治疗急性胰腺炎,见效快、效果明显,值得临床推广。
Objective: To observe and discuss the clinical effect of octreotide combined with ulinastatin in the treatment of acute pancreatitis. Methods: Seventy patients with acute pancreatitis from February 2011 to December 2013 in our hospital were selected as the study subjects. Patients were randomly divided into observation group (35 cases) and control group (35 cases). The control group was treated with octreotide, and the patients in the observation group were given ulinastatin on the basis of this. The clinical effects of two groups were compared. Results: The total effective rate in the observation group was 91.4%, which was significantly higher than that in the control group (74.3%). The amylase recovery time and the average length of hospital stay in the observation group were better than those in the control group (P <0.05). Conclusion: Octreotide combined with ulinastatin in the treatment of acute pancreatitis, quick, effective and worthy of clinical promotion.